CrystecPharma
Wendy Towler is an accomplished professional with extensive experience in business management and administration. Currently serving as Business Manager at CrystecPharma Ltd. since October 2018, Wendy has previously held the position of Executive Assistant to the Dean at the University of Bradford, where responsibilities included coordinating programs for graduate entrepreneurs. Prior to this, Wendy worked as a Risk Manager at RBS for three decades, beginning in September 1983 and concluding in August 2013. Wendy received education from Bingley Grammar School.
This person is not in any teams
CrystecPharma
Crystec Pharma is focused on applying supercritical fluid technology to improve the performance of medicines. We provide crystal and particle engineering solutions to the pharmaceutical industry, contributing to human health by enabling new and more effective therapies. Applications of our mSAS® (modified Supercritical Anti-Solvent) technology include enhancing the dissolution and bioavailability of drugs, optimising release profiles, as well as improving stability and processing characteristics. Our solutions include the following: • Crystal and particle engineering • Stabilisation of therapeutic agents derived from biotechnology • Polymorph screening • Improved performance of poorly soluble drugs • Improved bioavailabilty of small molecules • Alternative routes of delivery such as inhaled therapy • Taste masking • Crystallisation seeds • Residual solvent elimination